Stock listing
Eirgenix, Inc.
Selected listing: 6589 · TWSE · TWD · TW
Eirgenix, Inc. (TWSE:6589), Health Technology. Latest release Dec 28, 2025: Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive…
- Ticker
- TWSE:6589
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TWSE
- Currency
- TWD
About Eirgenix, Inc.
Eirgenix, Inc. is a publicly traded company on the Taiwan stock market under the ticker 6589. Eirgenix focuses on biopharmaceutical development, contributing to advancements in healthcare.
Latest news from Eirgenix, Inc.
Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics
December 27, 2025
/C O R R E C T I O N -- EirGenix, Inc./
November 12, 2025
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A
November 12, 2025
EirGenix : The Company’s Board of Directors Resolved to Issue Employee Stock Warrants.
August 11, 2022
EirGenix : Announcement of Board approve the permission of managers for competitive actions.
August 11, 2022